Triage of atypical squamous cells of undetermined significance with hybrid capture II: Colposcopy and histologic human papillomavirus correlation

Obstetrics and Gynecology

Volumn 101, Issue 3, 2003, Pages 481-489

  Lonky, Neal M ^a   Felix, Juan C ^b   Naidu, Yathi M ^b   Wolde Tsadik, Girma ^b  

^a Southern California Permanente Medical Group   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; ARTICLE; BIOPSY; CANCER GRADING; COLPOSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOLOGY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYBRID; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; RISK FACTOR; SCREENING; SQUAMOUS CELL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS;

EID: 0037335409     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(02)02715-1     Document Type: Article

References (28)

1. Davey D.D., Naryshkin S., Nielsen M.L., Kline T.S. Atypical squamous cells of undetermined significance Interlaboratory comparison and quality assurance monitors . Diagn Cytopathol. 11:1994;390-396.
2. Kurman R.J., Henson D.E., Herbst A.L., Noller K.L., Schiffman M.H. Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA. 271:1994;1866-1869.
3. Collins L.C., Wang H.H., Abu-Jawdeh G.M. Qualifiers of atypical squamous cells of undetermined significance help in patient management. Mod Pathol. 9:1996;677-681.
4. Kinney W.K., Manos M.M., Hurley L.B., Ransley J.E. Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol. 91:1998;973-976.
5. Lonky N.M., Sadeghi M., Tsadik G.W., Petitti D. The clinical significance of the poor correlation of cervical dysplasia and cervical malignancy with referral cytologic results. Am J Obstet Gynecol. 181:1999;560-566.
6. Cox J.T. Clinical role of HPV testing. Obstet Gyneoclol Clin North Am. 23:1996;811-851.
7. Wright T.C. Jr, Cox J.T., Massad L.S., Twiggs L.B., Wilkinson E.J. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA. 287:2002;2120-2129.
8. Kaufman R.H. Is there a role for human papillomavirus testing in clinical practice? Obstet Gynecol. 98:2001;724-725.
9. Herbst A.L., Pickett K.E., Follen M., Noller K.L. The management of ASCUS cervical cytologic abnormalities and HPV testing A cautionary note . Obstet Gynecol. 98:2001;849-851.
10. Lonky N.M. Perspectives in cervical cancer prevention and health services management. J Lower Genital Tract Dis. 3:1999;123-130.
11. Lytwyn A., Sellors J.W., Mahony J.B., Daya D., Chapman W., Ellis N., et al. Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities A randomized trial. HPV Effectiveness in Lowgrade Papanicolaous (HELP) Study No. 1 Group . Can Med Assoc J. 163:2000;701-707.
12. Slawson D.C., Bennett J.H., Simon L.J., Herman J.M. Should all women with cervical atypia be referred for colposcopy A HARNET study. Harrisburgh Area Research Network . J Fam Pract. 38:1994;387-392.
13. Morin C., Bairati I., Bouchard C., Fortier M., Roy M., Moore L., et al. Managing atypical squamous cells of undetermined significance in Papanicolaou smears. J Reprod Med. 46:2001;799-805.
14. Manos M.M., Kinney W.K., Hurley L.B., Sherman M.E., Shieh-Ngai J., Kurman R.J., et al. Identifying women with cervical neoplasia Using human papillomavirus DNA testing for equivocal Papanicolaou results . JAMA. 281:1999;1605-1610.
15. Solomon D., Schiffman M., Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance Baseline results from a randomized trial . J Natl Cancer Inst. 93:2001;293-299.
16. Lonky N.M., Navarre G.L., Saunders S., Sadeghi M., Wolde-Tsadik G. Low-grade Papanicolaou smears and the Bethesda system A prospective cytohistopathologic analysis . Obstet Gynecol. 85:1995;716-720.
17. Kleter B., van Doorn L.J., ter Schegget J., Schrauwen L., van Krimpen K., Burger M., et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol. 153:1998;1731-1739.
18. Gibbons J.D. Nonparametric statistical inference. 2nd edition :1985;Marcel Dekker, New York.
19. Agresti A. Categorical data analysis. 1990;John Wiley & Sons, New York.
20. Sherman M.E., Tabbara S.O., Scott D.R., Kurman R.J., Glass A.G., Manos M.M., et al. "ASCUS, rule out high grade SIL" Cytologic features, histologic correlates, and human papillomavirus detection . Mod Pathol. 12:1999;335-342.
21. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M., et al. The 2001 Bethesda system Terminology for reporting results of cervical cytology . JAMA. 287:2002;2114-2119.
22. Massad L.S., Halperin C.J., Bitterman P. Correlation between colposcopically directed biopsy and cervical loop excision. Gynecol Oncol. 60:1996;400-403.
23. Stoler M.H., Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations Realistic estimates from the ASCUS-LSIL Triage Study . JAMA. 285:2001;1500-1505.
24. Vessey C.J., Wilding J., Folarin N., Hirano S., Takeichi M., Soutter P., et al. Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. J Pathol. 176:1995;151-159.
25. Felix J.C., Lonky N.M., Tamura K., Yu K.J., Naidu Y., Lai C.R., et al. Aberrant expression of E-caderin in cervical intraepithelial neoplasia correlates with a false negative Papanicolaou smear. Am J Obstet Gynecol. 186:2002;1308-1314.
26. Schiffman M., Herrero R., Hildesheim A., Sherman M.E., Bratti M., Wacholder S., et al. HPV DNA testing in cervical cancer screening Results from women in a high-risk province of Costa Rica . JAMA. 283:2000;87-93.
27. Costa S., Sideri M., Syrjanen K., Terzano P., De Nuzzo M., De Simone P., et al. Combined Papanicolaou smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer. Acta Cytol. 44:2000;310-318.
28. Massad L.S., Lonky N.M., Mutch D.G., Finan M., Blanco J., Scotti R. Use of speculoscopy in the evaluation of women with atypical Papanicolaou smears Improved cost effectiveness by selective colposcopy . J Reprod Med. 38:1993;163-169.